Xencor to Present at Upcoming Investor Conferences

Rhea-AI Summary

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company focused on engineered monoclonal antibodies and cytokines for cancer and autoimmune diseases, announced participation in two investor conferences. The Piper Sandler 33rd Annual Virtual Healthcare Conference is scheduled for November 22, 2021 at 10:00 a.m. EST. The Evercore ISI 4th Annual HealthconX Conference will take place on December 1, 2021 at 1:00 p.m. EST. Webcasts of these presentations will be available for 30 days on their website.

MONROVIA, Calif.--(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming investor conferences:

• Piper Sandler 33rd Annual Virtual Healthcare Conference
  Presentation Available: Monday, November 22, 2021, 10:00 a.m. EST / 7:00 a.m. PST

• Evercore ISI 4th Annual HealthconX Conference
  Presentation Date: Wednesday, December 1, 2021, 1:00 p.m. EST / 10:00 a.m. PST

Webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. A replay of the live Evercore ISI presentation will be posted on the Xencor website approximately one hour after the live event. Both presentations will be available on the website for at least 30 days.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 22 candidates engineered with Xencor's XmAb^® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211119005693/en/

Charles Liles

cliles@xencor.com

Media Contact

Jason I. Spark

Canale Communications

619-849-6005

jason@canalecomm.com

Source: Xencor, Inc.

FAQ

When will Xencor present at the Piper Sandler 33rd Annual Virtual Healthcare Conference?

Xencor will present at the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 22, 2021, at 10:00 a.m. EST.

What is the date for Xencor's presentation at the Evercore ISI 4th Annual HealthconX Conference?

Xencor's presentation at the Evercore ISI 4th Annual HealthconX Conference is scheduled for December 1, 2021, at 1:00 p.m. EST.

Where can I watch Xencor's conference presentations?

Xencor's conference presentations will be available as webcasts on their website under the 'Events & Presentations' section.

How long will the webcasts of Xencor's presentations be available?

The webcasts of Xencor's presentations will be available for at least 30 days after the events.

What is Xencor known for?

Xencor is known for developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases.